Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia

Medicine & Life Sciences

• Allogeneic Cells 14%
• Amphotericin B 87%
• Aspergillosis 15%
• Data Analysis 4%
• deoxycholate drug combination amphotericin B 21%
• Duration of Therapy 6%
• Electrolytes 6%
• Fever of Unknown Origin 8%
• Fluconazole 90%
• Industry 6%
• Invasive Fungal Infections 33%
• Libraries 5%
• liposomal amphotericin B 27%
• MEDLINE 5%
• Morbidity 3%
• Mortality 6%
• Mycoses 33%
• Neoplasms 25%
• Neutropenia 78%
• Opportunistic Infections 7%
• Pharmaceutical Preparations 5%
• Premedication 7%
• Randomized Controlled Trials 4%
• Salts 5%
• Stem Cell Transplantation 13%
• Survival 7%
• Therapeutics 9%
• Voriconazole 100%
• Water 4%